AIMS: To examine the ability of fasting plasma glucose (FPG) and/or 2-h glucose to confirm diabetes and to determine the proportion of participants with HbA1c ≥6.5%. METHODS:Diabetes confirmation rates were calculated after a single elevated FPG and/or 2-h glucose on an oral glucose tolerance test (OGTT) using a confirmatory OGTT performed within 6 weeks. RESULTS: 772 (24%) participants had elevated FPG or 2-h glucose on an OGTT that triggered a confirmation visit. There were 101 triggers on FPG alone, 574 on 2-h glucose alone, and 97 on both. Only 47% of participants who triggered had confirmed diabetes. While the confirmation rate for FPG was higher than that for 2-h glucose, the larger number of 2-h glucose triggers resulted in 87% of confirmed cases triggering on 2-h glucose. Confirmation rates increased to 75% among persons with FPG ≥126 mg/dl and HbA1c ≥6.5%. CONCLUSIONS: Only half of the persons with elevated FPG and IGT were subsequently confirmed to have diabetes. At current diagnostic levels, more persons trigger on 2-h glucose than on FPG, but fewer of these persons have their diagnoses confirmed. In individuals with FPG ≥126 mg/dl and HbA1c ≥6.5%, the confirmation rate was increased.
RCT Entities:
AIMS: To examine the ability of fasting plasma glucose (FPG) and/or 2-h glucose to confirm diabetes and to determine the proportion of participants with HbA1c ≥6.5%. METHODS:Diabetes confirmation rates were calculated after a single elevated FPG and/or 2-h glucose on an oral glucose tolerance test (OGTT) using a confirmatory OGTT performed within 6 weeks. RESULTS: 772 (24%) participants had elevated FPG or 2-h glucose on an OGTT that triggered a confirmation visit. There were 101 triggers on FPG alone, 574 on 2-h glucose alone, and 97 on both. Only 47% of participants who triggered had confirmed diabetes. While the confirmation rate for FPG was higher than that for 2-h glucose, the larger number of 2-h glucose triggers resulted in 87% of confirmed cases triggering on 2-h glucose. Confirmation rates increased to 75% among persons with FPG ≥126 mg/dl and HbA1c ≥6.5%. CONCLUSIONS: Only half of the persons with elevated FPG and IGT were subsequently confirmed to have diabetes. At current diagnostic levels, more persons trigger on 2-h glucose than on FPG, but fewer of these persons have their diagnoses confirmed. In individuals with FPG ≥126 mg/dl and HbA1c ≥6.5%, the confirmation rate was increased.
Authors: E A Carter; J W MacCluer; B Dyke; B V Howard; R B Devereux; S O E Ebbesson; H E Resnick Journal: Diabetologia Date: 2005-12-21 Impact factor: 10.122
Authors: Richard R Rubin; Wilfred Y Fujimoto; David G Marrero; Tina Brenneman; Jeanne B Charleston; Sharon L Edelstein; Edwin B Fisher; Ruth Jordan; William C Knowler; Lynne C Lichterman; Melvin Prince; Patricia M Rowe Journal: Control Clin Trials Date: 2002-04
Authors: William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan Journal: N Engl J Med Date: 2002-02-07 Impact factor: 91.245
Authors: K M Flegal; T M Ezzati; M I Harris; S G Haynes; R Z Juarez; W C Knowler; E J Perez-Stable; M P Stern Journal: Diabetes Care Date: 1991-07 Impact factor: 19.112
Authors: Sarah Stark Casagrande; Andy Menke; Larissa Aviles-Santa; Linda C Gallo; Martha L Daviglus; Gregory A Talavera; Sheila F Castañeda; Krista Perreira; Matthew Shane Loop; Wassim Tarraf; Hector M González; Catherine C Cowie Journal: Diabetes Res Clin Pract Date: 2018-11-09 Impact factor: 5.602
Authors: Juan M A Alcantara; Guillermo Sanchez-Delgado; Lucas Jurado-Fasoli; Jose E Galgani; Idoia Labayen; Jonatan R Ruiz Journal: Eur J Nutr Date: 2022-08-25 Impact factor: 4.865
Authors: Erin S LeBlanc; Richard E Pratley; Bess Dawson-Hughes; Myrlene A Staten; Patricia R Sheehan; Michael R Lewis; Anne Peters; Sun H Kim; Ranee Chatterjee; Vanita R Aroda; Chhavi Chadha; Lisa M Neff; Irwin G Brodsky; Clifford Rosen; Cyrus V Desouza; John P Foreyt; Daniel S Hsia; Karen C Johnson; Philip Raskin; Sangeeta R Kashyap; Patrick O'Neil; Lawrence S Phillips; Neda Rasouli; Emilia P Liao; David C Robbins; Anastassios G Pittas Journal: Diabetes Care Date: 2018-06-25 Impact factor: 19.112
Authors: Ying Liu; Yang Yu; Jeffrey C Nickel; Laura R Iwasaki; Peipei Duan; Melanie Simmer-Beck; Laura Brown Journal: Int Dent J Date: 2018-05-22 Impact factor: 2.607
Authors: Timothy M Dall; K M Venkat Narayan; Karin B Gillespie; Paul D Gallo; Tericke D Blanchard; Mihaela Solcan; Michael O'Grady; William W Quick Journal: Popul Health Metr Date: 2014-05-07
Authors: Elizabeth Selvin; Dan Wang; Alexandra K Lee; Richard M Bergenstal; Josef Coresh Journal: Ann Intern Med Date: 2017-10-24 Impact factor: 25.391
Authors: Wenya Yang; Timothy M Dall; Eleonora Tan; Erin Byrne; William Iacobucci; Ritashree Chakrabarti; F Ellen Loh Journal: Prev Med Rep Date: 2018-03-28